These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17575374)

  • 21. Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias.
    Ozasa M; Ichikawa H; Sato S; Tanaka T; Johkoh T; Kataoka K; Yamano Y; Kondoh Y; Nakamura H; Kawakami A; Bychkov A; Taniguchi H; Fukuoka J
    PLoS One; 2018; 13(11):e0206186. PubMed ID: 30395623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
    Hoeper MM; Behr J; Held M; Grunig E; Vizza CD; Vonk-Noordegraaf A; Lange TJ; Claussen M; Grohé C; Klose H; Olsson KM; Zelniker T; Neurohr C; Distler O; Wirtz H; Opitz C; Huscher D; Pittrow D; Gibbs JS
    PLoS One; 2015; 10(12):e0141911. PubMed ID: 26630396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
    Kreuter M; Ehlers-Tenenbaum S; Schaaf M; Oltmanns U; Palmowski K; Hoffmann H; Schnabel PA; Heußel CP; Puderbach M; Herth FJ; Warth A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):266-74. PubMed ID: 25591137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A prospective study of idiopathic interstitial pneumonia and collagen vascular disease preceded by interstitial pneumonia].
    Ohtsuka Y; Homma Y; Tanimura K; Ogasawara H; Kusaka H; Munakata M; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1209-13. PubMed ID: 2266627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-endothelial cell antibodies in patients with interstitial lung diseases.
    Matsui T; Inui N; Suda T; Chida K
    Respir Med; 2008 Jan; 102(1):128-33. PubMed ID: 17851060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.
    Kono M; Nakamura Y; Yoshimura K; Enomoto Y; Oyama Y; Hozumi H; Enomoto N; Fujisawa T; Inui N; Hamada E; Colby TV; Maekawa M; Suda T
    Respir Med; 2016 Aug; 117():40-7. PubMed ID: 27492512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Pulmonary Hypertension on Intrahospital Mortality in Lung Transplantation for Interstitial Lung Disease.
    Corral-Blanco M; Prudencio-Ribera VC; Jarrín-Estupiñán ME; Alonso-Moralejo R; Pérez-González V; Meneses-Pardo JC; Hermira-Anchuelo A; De Pablo-Gafas A
    Transplant Proc; 2019 Mar; 51(2):380-382. PubMed ID: 30879546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
    Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
    J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia.
    Todd NW; Lavania S; Park MH; Iacono AT; Franks TJ; Galvin JR; Jeudy J; Britt EJ; Luzina IG; Hasday JD; Atamas SP
    J Heart Lung Transplant; 2010 Feb; 29(2):188-94. PubMed ID: 20113909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregability in patients with interstitial pneumonias.
    Handa T; Watanabe K; Tanizawa K; Oga T; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Hirai T; Nagai S; Chin K; Horiuchi H; Mishima M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):143-50. PubMed ID: 27537717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Present status of idiopathic interstitial pneumonia--from epidemiology to etiology].
    Munakata M; Asakawa M; Hamma Y; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():187-92. PubMed ID: 7602830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary manifestation of collagen vascular diseases: role of cytokines in interstitial pneumonia associated with collagen vascular diseases].
    Ishioka S; Maeda A; Hiyama K; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():277-83. PubMed ID: 8752519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of pulmonary vascular reserve on exercise-induced pulmonary hypertension in patients with systemic sclerosis.
    Suzuki K; Izumo M; Kamijima R; Mizukoshi K; Takai M; Kida K; Yoneyama K; Nobuoka S; Yamada H; Akashi YJ
    Echocardiography; 2015 Mar; 32(3):428-35. PubMed ID: 25104236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of sildenafil in interstitial pneumonia with pulmonary hypertension].
    Watanabe N; Taniguchi H; Kondoh Y; Kimura T; Kataoka K
    Nihon Kokyuki Gakkai Zasshi; 2011 Mar; 49(3):151-5. PubMed ID: 21485145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical assessment for pulmonary hypertension in interstitial lung disease.
    Chan RK; Horrigan M; Goh NSL; Khor YH
    Intern Med J; 2023 Aug; 53(8):1415-1422. PubMed ID: 35848362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia.
    Kata Y; Hara Y; Murohashi K; Saigusa Y; Nagasawa R; Tagami Y; Fujii H; Aoki A; Nishikawa Y; Tanaka K; Watanabe K; Horita N; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
    Nagoya J Med Sci; 2023 Aug; 85(3):602-611. PubMed ID: 37829474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
    Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
    Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?
    Nathan SD; Behr J; Cottin V; Collard HR; Hoeper MM; Martinez FJ; Wells AU
    Respir Med; 2017 Jan; 122 Suppl 1():S10-S13. PubMed ID: 27884593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.